Federal Committee Reviews Hepatitis B Vaccination Guidelines for Newborns

Fri Dec 05 2025 13:42:44 GMT+0200 (Eastern European Standard Time)

A federal vaccine advisory committee debates whether to continue the universal hepatitis B vaccination of newborns at birth, potentially reverting to previous recommendations.

In a critical meeting on Thursday in Atlanta, a federal vaccine advisory committee, led by Health Secretary Robert F. Kennedy Jr., discussed the necessity of giving newborns the hepatitis B vaccine immediately after birth. While traditionally advised for all infants, the committee is considering recommending the birth dose solely for babies born to infected mothers. Health experts share concerns on this proposed shift in public health strategy, highlighting the implications for children’s health. The committee's recommendations influence vaccination programs nationwide, raising alarms among medical professionals regarding the potential rollback of established vaccination practices.

A federal vaccine advisory committee convened Thursday in Atlanta to discuss whether newborns should still get the hepatitis B vaccine on the day they’re born.

For decades, the government has advised that all babies be vaccinated against the liver infection right after birth. The shots are widely considered to be a public health success for preventing thousands of illnesses.

However, U.S. Health Secretary Robert F. Kennedy Jr.’s committee is considering whether to recommend the birth dose only for babies whose mothers test positive for the virus, marking a return to a public health strategy that was abandoned over three decades ago. For other infants, the decision would be left to parents and their healthcare providers.

Committee member Vicky Pebsworth mentioned that a work group was tasked in September with evaluating the necessity of the birth dose for infants when their mothers tested negative for hepatitis B.

“We need to address stakeholder and parent dissatisfaction” with current recommendations, she highlighted.

The committee's recommendations play a significant role in the policies of the Centers for Disease Control and Prevention (CDC), with directors typically adopting their suggestions for medical practice. However, given that the CDC currently lacks a permanent director, the decision now lies with acting director Jim O’Neill.

Moreover, Kennedy, before assuming the role of Health Secretary, was known as a prominent anti-vaccine activist. Earlier this year, he dismissed the entire 17-member committee and replaced it with a group containing multiple anti-vaccine voices, leading to significant contention among medical professionals regarding new policy proposals.

During previous committee meetings, recommendations made have been met with criticism from major medical organizations. For instance, they suggested the removal of a preservative from flu vaccines without evidence of harm, proposed new restrictions on combination vaccines, and controversially recommended against COVID-19 vaccinations for high-risk demographics.

The hepatitis B virus can cause serious health complications, particularly in infants who are significantly more likely to develop chronic infections. Consequently, the initial vaccination, introduced in 1991, successfully reduced cases among children from 18,000 annually to approximately 2,200.

As the committee contemplates this profound change in pediatric vaccination policy, many advocate for the continuation of established practices while raising concerns over the inclusion of anti-vaccine ideologies in health decisions.